Contaminated vials of injectable antibiotic recalled
A kind of injectable antibiotic is being recalled by a U.S. subsidiary of a German pharmaceutical company due to potential contamination that can cause serious health risks, a report from the U.S. Food and Drug Administration (FDA) stated on October 15.
The recall affects the Cefepime for Injection USP and Dextrose Injection USP antibiotic, which may have been contaminated with hair, small metal bits, and cotton fibers. The intravenous drug was recalled after contaminants were discovered in a sample vial. According to the FDA, the contaminated antibiotic made by B. Braun Melsungen, which is widely used in US hospitals, can cause serious health problems for patients, like blood clots, strokes, and heart attacks.
Patients are advised to immediately consult a doctor if they experience problems as a result of using the recalled antibiotic and report the incident to B. Braun.
When a person is harmed by a dangerous drug, he or she might suffer from multiple side effects, ranging from physical harm to financial burdens. If you are going through such a situation in Iowa, the legal team at LaMarca Law Group, P.C., may be able to help you seek compensation from the negligent manufacturer. Discuss your situation more in depth by calling 877-327-2600 today.